跳转至内容
Merck
CN

1.05040

碘化钾

EMPROVE® API, Ph. Eur., BP, ChP, JP, USP

登录 查看组织和合同定价。

选择尺寸

关于此项目

线性分子式:
KI
化学文摘社编号:
7681-11-0
分子量:
166.00
UNSPSC Code:
12352302
EC Index Number:
231-659-4
MDL number:
MFCD00011405

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

碘化钾, EMPROVE® API, Ph. Eur., BP, ChP, JP, USP

InChI

1S/HI.K/h1H;/q;+1/p-1

SMILES string

[K+].[I-]

InChI key

NLKNQRATVPKPDG-UHFFFAOYSA-M

agency

BP
ChP
JP
Ph. Eur.
USP

vapor pressure

1 mmHg ( 745 °C)

product line

EMPROVE® API

form

solid

potency

2779 mg/kg LD50, oral (Rat)

pH

6.9 (20 °C, 50 g/L in H2O)

bp

1325 °C/1013 hPa

mp

681 °C (lit.)

bulk density

1500 kg/m3

application(s)

liquid formulation
pharmaceutical
semi-solid formulation
solid formulation

storage temp.

2-25°C

Quality Level

600

正在寻找类似产品? 访问 产品对比指南

相关类别

Application

Potassium iodide is used in medicine to treat thyroid subfunction, as a trace element for iodide source in clinical nutrition and in dietary supplements. Potassium iodide Emprove® API is manufactured according to ICH Q7 guidelines. A CEP and US-DMF are available.

General description

We provide industry-leading production know-how and comprehensive regulatory support for high-quality APIs, backed by nearly 200 years of experience. From a complete portfolio of innovative folates to custom synthesis, our customized and scalable solutions meet your specific production needs. As part of our EMPROVE® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

Legal Information

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

pictograms

Health hazard
GHS08

signalword

Danger

hcodes

H372

Hazard Classifications

STOT RE 1 Oral

target_organs

Thyroid

存储类别

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

wgk

WGK 3

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

商品

Strategies for the Development of Safe and Effective Pediatric Formulations

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

相关内容

Pediatric Formulations

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

APIs Tailored to Your Needs.
APIs de acordo com as suas necessidades
Principios activos a la medida de

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持